The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The Warburg Effect in Leukemia-Stroma Cocultures Is Mediated by Mitochondrial Uncoupling Associated with Uncoupling Protein 2 Activation
Open accessPublished version of a preprint
Abstract
In 1956, Otto Warburg proposed that the origin of cancer cells was closely linked to a permanent respiratory defect that bypassed the Pasteur effect (i.e., the inhibition of anaerobic fermentation by oxygen). Since then, permanent defects in oxygen consumption that could explain the dependence of cancer cells on aerobic glycolysis have not been identified. Here, we show that under normoxic conditions exposure of leukemia cells to bone marrow-derived mesenchymal stromal cells (MSC) promotes accumulation of lactate in the culture medium and reduces mitochondrial membrane potential (DeltaPsiM) in both cell types. Notably, the consumption of glucose was not altered in cocultures, suggesting that the accumulation of lactate was the result of reduced pyruvate metabolism. Interestingly, the decrease in DeltaPsiM was mediated by mitochondrial uncoupling in leukemia cells and was accompanied by increased expression of uncoupling protein 2 (UCP2). HL60 cells fail to increase UCP2 expression, are not uncoupled after coculture, and do not exhibit increased aerobic glycolysis, whereas small interfering RNA-mediated suppression of UCP2 in OCI-AML3 cells reversed mitochondrial uncoupling and aerobic glycolysis elicited by MSC. Taken together, these data suggest that microenvironment activation of highly conserved mammalian UCPs may facilitate the Warburg effect in the absence of permanent respiratory impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the critical role of UCP2 (uncoupling protein 2) in promoting aerobic glycolysis and inhibiting oxidative phosphorylation has been established from multiple experimental models (Pecqueur et al., 2008; Samudio et al., 2008; Bouillaud, 2009; Zhang et al., 2011).”
From Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation (2016) · cites this paper as Samudio et al., 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Konopleva, M. Y., Contractor, R., Tsao, T., Samudio, I. J., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T. B., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,043
Self-citationCossarizza, A., Baccarani-Contri, M., Kalashnikova, G., & Franceschi, C. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2438 · Cited by 1,031
The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP
Ricquier, D., & Bouillaud, F. (2000) · Biochemical Journal · doi:10.1042/bj3450161 · Cited by 811
Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3
Brand, M. D., & Esteves, T. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.002 · Cited by 785
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616
A signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling
Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero‐Otín, M., Pamplona, R., Vidal‐Puig, A. J., Wang, S., Roebuck, S. J., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg412 · Cited by 597
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520
Mattiasson, G., Shamloo, M., Gido, G., Mathi, K., Tomasevic, G., Yi, S., Warden, C. H., Castilho, R. F., Melcher, T., Gonzalez-Zulueta, M., et al. (2003) · Nature Medicine · doi:10.1038/nm903 · Cited by 515
Budd, S. L., & Nicholls, D. G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062282.x · Cited by 435
Cited by
Sorted by citations
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3483 · Cited by 1,353
Samudio, I. J., Harmancey, R., Fiegl, M., Kantarjian, H. M., Konopleva, M. Y., Korchin, B., Kaluarachchi, K. K., Bornmann, W. G., Duvvuri, S. R., Taegtmeyer, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 737
Self-citationZheng, X., Boyer, L., Jin, M., Mertens, J., Kim, Y., Ma, L., Ma, L., Hamm, M., Gage, F. H., & Hunter, T. (2016) · eLife · doi:10.7554/elife.13374 · Cited by 671
“In addition to the conventional regulators of glycolysis, TCA and oxidative phosphorylation, the critical role of UCP2 (uncoupling protein 2) in promoting aerobic glycolysis and inhibiting oxidative phosphorylation has been established from multiple experimental models (Pecqueur et al., 2008; Samudio et al., 2008; Bou…”
MethodUCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells
Zhang, J., Khvorostov, I., Hong, J. S., Oktay, Y., Vergnes, L., Nuebel, E., Wahjudi, P. N., Setoguchi, K., Wang, G., Do, A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.401 · Cited by 512
Phan, L. M., Yeung, S. J., & Lee, M. H. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 512
Moschoi, R., Imbert, V., Nebout, M., Chiche, J., Mary, D. A. S. G., Prébet, T., Saland, E., Castellano, R., Pouyet, L., Collette, Y., et al. (2016) · Blood · doi:10.1182/blood-2015-07-655860 · Cited by 467
UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation
Vozza, A., Parisi, G., De Leonardis, F., Lasorsa, F. M., Castegna, A., Amorese, D., Marmo, R., Calcagnile, V. M., Palmieri, L., Ricquier, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317400111 · Cited by 407
The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
Nepstad, I., Hatfield, K. J., Grønningsæter, I. S., & Reikvam, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082907 · Cited by 365
The metabolism of human mesenchymal stem cells during proliferation and differentiation
Pattappa, G., Heywood, H. K., de Bruijn, J. D., & Lee, D. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22605 · Cited by 336
Mitochondrial Channels: Ion Fluxes and More
Szabó, I., & Zoratti, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00021.2013 · Cited by 330
Samudio, I. J., Fiegl, M., & Andreeff, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3722 · Cited by 309
Self-citationThe Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 252
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedGlut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Zambrano, Á., Molt, M., Uribe, E. A., & Salas, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133374 · Cited by 220
Rattigan, Y. I., Patel, B. B., Ackerstaff, E., Sukenick, G., Koutcher, J. A., Glod, J. W., & Banerjee, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.014 · Cited by 196
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S. M., Lodi, A., Sweeney, S. R., Ma, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12944 · Cited by 185
Self-citationMetabolic Plasticity in Chemotherapy Resistance
Desbats, M. A., Giacomini, I., Prayer‐Galetti, T., & Montopoli, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00281 · Cited by 190
Mesenchymal Stem Cells: Flip Side of the Coin
Mishra, P. J., Mishra, P. J., Glod, J. W., & Banerjee, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3562 · Cited by 181
Martinez‐Outschoorn, U., Goldberg, A. F., Zhao, L., Ko, Y., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17780 · Cited by 180
Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy
Mohammadalipour, A., Dumbali, S. P., & Wenzel, P. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603292 · Cited by 182
UCP2, a mitochondrial protein regulated at multiple levels
Donadelli, M., Dando, I., Fiorini, C., & Palmieri, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1407-0 · Cited by 175
Myeloid malignancies and the microenvironment
Korn, C., & Méndez‐Ferrer, S. (2016) · Blood · doi:10.1182/blood-2016-09-670224 · Cited by 170
Vanniarajan, A., Owens, K. M., Desouki, M. M., Liang, P., Bakin, A. V., Kumarasamy Thangaraj, K., Buchsbaum, D. J., LoBuglio, A. F., & Singh, K. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024792 · Cited by 151
Bouillaud, F. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.01.003 · Cited by 146
Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Shoshan‐Barmatz, V., & Golan, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712798992110 · Cited by 142
Hao, W., Chang, C.-P. B., Tsao, C.-C., & Xu, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084194 · Cited by 138
Potential role of genipin in cancer therapy
Shanmugam, M. K., Shen, H., Tang, F. R., Arfuso, F., Rajesh, M., Wang, L., Kumar, A. P., Bian, J., Goh, B. C., Bishayee, A., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.05.007 · Cited by 143
Liao, Z., Li, S., Lu, S., Liu, H., Li, G., Ma, L., Luo, R., Ke, W., Wang, B., Xiang, Q., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120850 · Cited by 135
Scotland, S., Saland, E., Skuli, N., de Toni, F., Boutzen, H., Micklow, E., Sénégas, I., Peyraud, R., Peyriga, L., Théodoro, F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.107 · Cited by 149
Intracellular ion channels and cancer
Leanza, L., Biasutto, L., Managò, A., Gulbins, E., Zoratti, M., & Szabó, I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00227 · Cited by 135
Ohkouchi, S., Block, G. J., Katsha, A. M., Kanehira, M., Ebina, M., Kikuchi, T., Saijo, Y., Nukiwa, T., & Prockop, D. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.259 · Cited by 121
Uncoupling protein-2 and cancer
Baffy, G. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.12.143 · Cited by 120
Sun, W., Liu, Y., Glazer, C. A., Shao, C., Bhan, S., Demokan, S., Zhao, M., Rudek, M. A., Ha, P. K., & Califano, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2604 · Cited by 123
Cai, J., Wang, J., Huang, Y., Wu, H., Xia, T., Xiao, J., Chen, X., Li, H., Qiu, Y., Wang, Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.370 · Cited by 117
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Tirado-Vélez, J. M., Joumady, I., Sáez-Benito, A., Cózar‐Castellano, I., & Perdomo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046484 · Cited by 113
Ono, M., Ohkouchi, S., Kanehira, M., Tode, N., Kobayashi, M., Ebina, M., Nukiwa, T., Irokawa, T., Ogawa, H., Akaike, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.217 · Cited by 112
Oxidative stress and hypoxia in normal and leukemic stem cells
Testa, U., Labbaye, C., Castelli, G., & Pelosi, E. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.04.012 · Cited by 118
Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy
Badrinath, N., & Yoo, S. Y. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy148 · Cited by 112
Mesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells
Blanquer-Rosselló, M. D. M., Hernández‐López, R., Roca, P., Oliver, J., & Valle, A. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.10.009 · Cited by 93
Metabolic features of macrophages in inflammatory diseases and cancer
Na, Y. R., Je, S., & Seok, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.044 · Cited by 96
Mitochondrial ion channels as oncological targets
Leanza, L., Zoratti, M., Gulbins, E., & Szabó, I. (2014) · Oncogene · doi:10.1038/onc.2013.578 · Cited by 93
UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism?
Pecqueur, C., Alves‐Guerra, M., Ricquier, D., & Bouillaud, F. (2009) · IUBMB Life · doi:10.1002/iub.188 · Cited by 92
Mitochondrial recoupling: a novel therapeutic strategy for cancer
Baffy, G., Derdak, Z., & Robson, S. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.245 · Cited by 88
“A better understanding of the molecular mechanisms that facilitate cancer cell survival should help guide novel therapeutic strategies.”
BackgroundLuo, Z., Yao, J., Wang, Z., & Xu, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04286-1 · Cited by 90
Non-glucose metabolism in cancer cells—is it all in the fat?
Biswas, S., Lunec, J., & Bartlett, K. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9384-6 · Cited by 86
Estèves, P., Pecqueur, C., Ransy, C., Esnous, C., Lenoir, V., Bouillaud, F., Bulteau, A., Lombès, A., Prip‐Buus, C., Ricquier, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3383 · Cited by 93
Increased Right Ventricular Glucose Metabolism in Patients With Pulmonary Arterial Hypertension
Can, M. M., Kaymaz, C., Tanboğa, İ. H., Tokgöz, H. C., Canpolat, N., Türkyılmaz, E., Sönmez, K., & Özdemir, N. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182177389 · Cited by 85
Uncoupling protein 2 and metabolic diseases
Sreedhar, A., & Zhao, Y. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.03.005 · Cited by 83
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Benito, J., Ramirez, M. S., Zacharias, N. M., Vélez, J., Harutyunyan, K. G., Lu, H., Shi, Y.-X., Matre, P. R., Jacamo, R. O., Ma, H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3378 · Cited by 79
Self-citationIL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
Kütt, A., Rieger, C. T., Perathoner, D., Herold, T., Wagner, M. M., Sironi, S., Sotlar, K., Horny, H., Deniffel, C., Drolle, H., et al. (2015) · Scientific Reports · doi:10.1038/srep18411 · Cited by 72
Self-citationForrest, M. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/025197 · Cited by 74
Brandi, J., Cecconi, D., Cordani, M., Torrens‐Mas, M., Pacchiana, R., Pozza, E. D., Butera, G., Manfredi, M., Marengo, E., Oliver, J., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.499 · Cited by 71
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 70
Cancer Stem Cell Theory and the Warburg Effect, Two Sides of the Same Coin?
Pacini, N., & Borziani, F. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058893 · Cited by 66
Ionizing radiation, ion transports, and radioresistance of cancer cells
Huber, S. M., Butz, L., Stegen, B., Klumpp, D., Braun, N., Ruth, P., & Eckert, F. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00212 · Cited by 69
Role of Uncoupling Proteins in Cancer
Valle, A., Oliver, J., & Roca, P. (2010) · Cancers · doi:10.3390/cancers2020567 · Cited by 71
Metabolic flexibility and cell hierarchy in metastatic cancer
Berridge, M. V., Herst, P. M., & Tan, A. S. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.08.002 · Cited by 70
Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia
Rosilio, C., Ben‐Sahra, I., Bost, F., & Peyron, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.006 · Cited by 63
Amano, Y., Mandai, M., Yamaguchi, K. D., Matsumura, N., Kharma, B., Baba, T., Abiko, K., Hamanishi, J., Yoshioka, Y., & Konishi, I. (2015) · Oncotarget · doi:10.18632/oncotarget.4692 · Cited by 58
Targeting the Warburg effect in hematological malignancies: from PET to therapy
Shanmugam, M., McBrayer, S. K., & Rosen, S. T. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832f57ec · Cited by 58
Ke, Q., Yuan, Q., Qin, N., Shi, C., Luo, J., Fang, Y., Xu, L., Sun, Q., Zen, K., Jiang, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2219-4 · Cited by 56
The Role of Tumor-Associated Macrophages in Hematologic Malignancies
Cencini, E., Fabbri, A., Sicuranza, A., Gozzetti, A., & Bocchia, M. (2021) · Cancers · doi:10.3390/cancers13143597 · Cited by 57
Li, W., Nichols, K., Nathan, C. O., & Zhao, Y. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130369 · Cited by 51
Nadal‐Serrano, M., Sastre‐Serra, J., Pons, D. G., Miró, A. M., Oliver, J., & Roca, P. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24192 · Cited by 52
Impact of intracellular ion channels on cancer development and progression
Peruzzo, R., Biasutto, L., Szabó, I., & Leanza, L. (2016) · European Biophysics Journal · doi:10.1007/s00249-016-1143-0 · Cited by 50
Tesfai, Y., Ford, J., Carter, K. W., Firth, M. J., O’Leary, R. A., Gottardo, N. G., Cole, C., & Kees, U. R. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.08.001 · Cited by 48
Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect
Xu, Y., Miriyala, S., Fang, F., Bakthavatchalu, V., Noel, T. J., Schell, D. M., Wang, C., Clair, W. H. S., & Clair, D. K. S. (2014) · Oncogene · doi:10.1038/onc.2014.355 · Cited by 49
Pizzuto, R., Paventi, G., Porcile, C., Sarnataro, D., Daniele, A., & Passarella, S. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.05.010 · Cited by 48
β3‐Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells
Calvani, M., Cavallini, L., Tondo, A., Spinelli, V., Ricci, L., Pasha, A., Bruno, G., Buonvicino, D., Bigagli, E., Vignoli, M., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6816508 · Cited by 51
Loussouarn, C., Pers, Y., Bony, C., Jørgensen, C., & Noël, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623973 · Cited by 47
Kouzi, F., Zibara, K., Bourgeais, J., Picou, F., Gallay, N., Brossaud, J., Dakik, H., Roux, B., Hamard, S., Nail, L. L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1069-y · Cited by 47
Su, W.-P., Lo, Y.-C., Yan, J., Liao, I., Tsai, P.-J., Wang, H., Yeh, H.-H., Lin, C., Chen, H. H. W., Lai, W., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs253 · Cited by 45
Mitochondrial Uncoupling and the Reprograming of Intermediary Metabolism in Leukemia Cells
Vélez, J., Hail, N., Konopleva, M. Y., Zeng, Z., Kojima, K., Samudio, I. J., & Andreeff, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00067 · Cited by 50
Self-citationCiciarello, M., Corradi, G., Loscocco, F., Visani, G., Monaco, F., Cavo, M., Curti, A., & Isidori, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01135 · Cited by 46
Ciciarello, M., Corradi, G., Forte, D., Cavo, M., & Curti, A. (2021) · Cancers · doi:10.3390/cancers13215319 · Cited by 45
Vélez, J., Pan, R. A., Lee, J. T. C., Enciso, L. J., Suarez, M., Duque, J. E., Jaramillo, D., López, C., Morales, L., Bornmann, W. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9843 · Cited by 41
Self-citationMitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia
Olivas-Aguirre, M., Pottosin, I. I., & Dobrovinskaya, O. R. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.5vmr0818-330rr · Cited by 42
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Cordani, M., Michetti, F., Zarrabi, A., Zarepour, A., Rumio, C., Strippoli, R., & Marcucci, F. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101076 · Cited by 40
Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia
Ricciardi, M. R., Mirabilii, S., Licchetta, R., Piedimonte, M., & Tafuri, A. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.05.002 · Cited by 41
Singh, A. K., & Cancelas, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030796 · Cited by 41
Rupprecht, A., Sittner, D., Тихоновна, С. А., Hilse, K. E., Goyn, J., Moldzio, R., Seiler, A. E. M., Bräuer, A. U., & Pohl, E. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088474 · Cited by 41
CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis
Braun, M., Qorraj, M., Büttner, M., Klein, F. A., Saul, D., Aigner, M., Huber, W. K., Mackensen, A., Jitschin, R., & Mougiakakos, D. (2016) · Leukemia · doi:10.1038/leu.2016.58 · Cited by 41
Shimasaki, Y., Pan, N., Messina, L. M., Li, C., Chen, K., Liu, L., Cooper, M. P., Vita, J. A., & Keaney, J. F. (2013) · Circulation Research · doi:10.1161/circresaha.113.301319 · Cited by 39
Epigenetic-Transcriptional Regulation of Fatty Acid Metabolism and Its Alterations in Leukaemia
Maher, M., Diesch, J., Casquero, R., & Buschbeck, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00405 · Cited by 39
Nagler, C., Hardt, C., Zänker, K. S., & Dittmar, T. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-21 · Cited by 38
Vélez, J., Enciso, L. J., Suarez, M., Fiegl, M., Grismaldo, A., López, C., Barreto, A., Cardozo, C., Palacios, P., Morales, L., et al. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0149-3 · Cited by 36
Self-citationCheng, Y., Diao, D., Zhang, H., Guo, Q., Wu, X., Song, Y., & Dang, C. (2013) · Biomedical Reports · doi:10.3892/br.2013.211 · Cited by 36
Allende-Vega, N., Krzywińska, E., Orecchioni, S., López-Royuela, N., Reggiani, F., Talarico, G., Rossi, J., Rossignol, R., Hicheri, Y., Cartron, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4653 · Cited by 40
Chen, B., Cai, T., Huang, C., Zang, X., Sun, L., Guo, S., Wang, Q., Chen, Z., Zhao, Y., Han, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.648706 · Cited by 34
Immunometabolism modulation, a new trick of edible and medicinal plants in cancer treatment
Tan, W., Pan, T., Wang, S., Li, P., Men, Y., Tan, R., Zhong, Z., & Wang, Y. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131860 · Cited by 35
Pardee, T. S., Luther, S., Buyse, M. E., Powell, B. L., & Cortes, J. E. (2019) · Future Oncology · doi:10.2217/fon-2019-0201 · Cited by 32
Tang, S., Yang, L., Tang, X., & Liu, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.028 · Cited by 33
Vasold, J., Wagner, M. M., Drolle, H., Deniffel, C., Kütt, A., Oostendorp, R. A. J., Sironi, S., Rieger, C. T., & Fiegl, M. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.12.001 · Cited by 31
Self-citationMetabolic Remodeling Induced by Adipocytes: A New Achilles' Heel in Invasive Breast Cancer?
Attané, C., Milhas, D., Hoy, A. J., & Muller, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180426165001 · Cited by 32
Rupprecht, A., Moldzio, R., Mödl, B., & Pohl, E. E. (2019) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2019.03.006 · Cited by 32
Catalano, G., Zaza, A., Banella, C., Pelosi, E., Castelli, G., Marinis, E. D., Smigliani, A., Travaglini, S., Ottone, T., Divona, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01946-5 · Cited by 30
From gametogenesis and stem cells to cancer: common metabolic themes
Pereira, S. L., Rodrigues, A. S., Sousa, M. I., Correia, M., Perestrelo, T., & Ramalho‐Santos, J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu034 · Cited by 33
BH3 Mimetics in AML Therapy: Death and Beyond?
Cerella, C., Dicato, M. A., & Diederich, M. F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.004 · Cited by 31
Metadata
- Authors
- Samudio, I., Fiegl, M., McQueen, T., Clise-Dwyer, K., & Andreeff, M.
- Affiliations
- 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, and
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Cancer Research
- Published
- 2008-07-01
- Volume
- 68
- Issue
- 13
- Pages
- 5198-5205
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2562568
- OpenAlex
- W2032999577
- Cited by
- 168
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 17 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 14 · 2015: 10 · 2014: 20 · 2013: 14 · 2012: 12
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01 CA-55164, P01CA055164)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Warburg effect, leukemia, mesenchymal stem cells, mitochondrial uncoupling, UCP2, aerobic glycolysis, mitochondrial membrane potential, lactate accumulation, pyruvate metabolism, bone marrow microenvironment, HL-60 cells, OCI-AML3 cells, oxygen consumption
- MeSH terms
- Uncoupling Protein 2, Aerobiosis, Bone Marrow Cells, Cells, Cultured, Glycolysis, Humans, Ion Channels, Leukemia, Mitochondria, Uncoupling Agents, Culture Media, Conditioned, Stromal Cells, Coculture Techniques, HL-60 Cells, Mitochondrial Proteins, Membrane Potential, Mitochondrial, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review